Sponsor pipeline

Shanghai Exuma Biotechnology Ltd. clinical trial pipeline

Get alerts when Shanghai Exuma Biotechnology Ltd.'s trials change

1 active trials 1 recruiting 3 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days

2026-09-12
Primary completion pushed: 2026-03-09 → 2029-04-28
Completion pushed: 2026-05-11 → 2029-09-18
NCT06830031 Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell… · Phase 1

Active trials by phase

Phase 1
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT06830031 Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell… Diffuse Large B-cell-lymphoma Recruiting 2026-09-11

Disease areas by active trials

DLBCL (1) · Follicular Lymphoma (1) · Non-Hodgkin Lymphoma (1)

Get alerts when Shanghai Exuma Biotechnology Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free